Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Ftse 100 Income UCITS ETF 1d
LU0292097234 · LU0292097234 · GBP · domicile Luxembourg
Equity · United Kingdom · Large capSFDR art. 6 (inferred)
Index tracked: FTSE 100 INDEX (GBP)
- TER
- 0.09%+ trans. 0.04%
- Fund size
- 99 m EUR
- Tracking difference
- −0.15%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingquarterly
Launch 5 Jun 2007 · costs from the KID as of 2 Sept 2026 · 106 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the FTSE 100 index (index) which is designed to reflect the performance of the shares of the largest 100 UK companies listed on the London Stock Exchange.
DESCRIPTION OF INDEX:
The companies are selected on the basis that they have the largest combined value of shares as compared to other companies on the London Stock Exchange. The composition of the index is reviewed quarterly.
INDEX REBALANCING, CALCULATION AND ADMINISTRATION:
The…
Performance since series start (in euro) — base 100
5 Jun 2007 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +22.5% |
| 3 years | +59.7% |
| 5 years | +80.4% |
| 10 years | +121.5% |
| Since series start | +154.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.11% | 11.24% | 12.67% |
| Max drawdown | −8.91% | −12.93% | −14.34% |
| Sharpe | 1.27 | 0.80 | 0.47 |
| Sortino | 1.86 | 1.11 | 0.64 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0292097234 · LU02920972341
RebalixLU0292097234 · LU0292097234 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +25.62% | +25.78% | −0.16% |
| 2024 | +9.50% | +9.63% | −0.13% |
| 2023 | +7.75% | +7.90% | −0.15% |
| 2022 | +4.57% | +4.67% | −0.10% |
| 2021 | +18.26% | +18.40% | −0.13% |
Distributions · per share, in GBP
Frequency: quarterly · last 12 months: 0.3006 GBP (2.86% of NAV) · last ex-date 19 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.2368 | — |
| 2025 | 4 | 0.2777 | +3.51% |
| 2024 | 4 | 0.3834 | +5.05% |
| 2023 | 4 | 0.2806 | +3.83% |
| 2022 | 4 | 0.5191 | +6.92% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 2 Sept 2026 · 106 securities · top-10 weight = 48.0%
| Top holdings | Weight |
|---|---|
| 10.1% | |
| 7.4% | |
| 6.9% | |
| 4.7% | |
| 3.9% | |
| 3.3% | |
| 3.3% | |
| 3.0% | |
| 2.9% | |
| 2.6% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
XUKX · Xetra (Deutsche Börse)
+ 23 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0292097234
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0292097234
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0292097234 · LU02920972342